198 related articles for article (PubMed ID: 18854424)
21. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.
Walther MM; Reiter R; Keiser HR; Choyke PL; Venzon D; Hurley K; Gnarra JR; Reynolds JC; Glenn GM; Zbar B; Linehan WM
J Urol; 1999 Sep; 162(3 Pt 1):659-64. PubMed ID: 10458336
[TBL] [Abstract][Full Text] [Related]
22. Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma.
Davidson DF; Bradshaw N; Perry CG; Lindsay R; Freel EM
Ann Clin Biochem; 2012 Sep; 49(Pt 5):486-90. PubMed ID: 22914444
[TBL] [Abstract][Full Text] [Related]
23. [Catecholamine-producing tumors].
Chávez Lara B
Arch Inst Cardiol Mex; 1991; 61(6):553-9. PubMed ID: 1793308
[TBL] [Abstract][Full Text] [Related]
24. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T
Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918
[TBL] [Abstract][Full Text] [Related]
26. Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.
Rao JU; Engelke UF; Rodenburg RJ; Wevers RA; Pacak K; Eisenhofer G; Qin N; Kusters B; Goudswaard AG; Lenders JW; Hermus AR; Mensenkamp AR; Kunst HP; Sweep FC; Timmers HJ
Clin Cancer Res; 2013 Jul; 19(14):3787-95. PubMed ID: 23723300
[TBL] [Abstract][Full Text] [Related]
27. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
28. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
29. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
[TBL] [Abstract][Full Text] [Related]
30. [A reevaluation of the glucagon provocative test for pheochromocytoma--on the in vitro release of catecholamine from the adrenal medulla or pheochromocytoma tissue, and on the effect of intravenous glucagon on urinary catecholamine excretion and blood pressure (author's transl)].
Nakai T; Yamada R; Baba M; Komiya E
Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):855-67. PubMed ID: 7409274
[TBL] [Abstract][Full Text] [Related]
31. [The diagnosis of atypical pheochromocytoma: a challenge for the biologist as well].
Peyrin L; Cottet-Emard JM; Cottet-Emard RM; Vouillarmet A
Pathol Biol (Paris); 2001 Apr; 49(3):247-54. PubMed ID: 11367560
[TBL] [Abstract][Full Text] [Related]
32. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
33. Current topics in pheochromocytoma.
Nakao K; Itoh H; Takaya K
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():124s-128s. PubMed ID: 10915008
[TBL] [Abstract][Full Text] [Related]
34. Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family.
Atuk NO; McDonald T; Wood T; Carpenter JT; Walzak MP; Donaldson M; Gillenwater JY
Medicine (Baltimore); 1979 May; 58(3):209-18. PubMed ID: 449657
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome.
Cleary S; Phillips JK; Huynh TT; Pacak K; Elkahloun AG; Barb J; Worrell RA; Goldstein DS; Eisenhofer G
J Endocrinol; 2007 May; 193(2):225-33. PubMed ID: 17470513
[TBL] [Abstract][Full Text] [Related]
36. Genetics of pheochromocytomas and paragangliomas.
Opocher G; Schiavi F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
[TBL] [Abstract][Full Text] [Related]
37. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
[TBL] [Abstract][Full Text] [Related]
38. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K
Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279
[TBL] [Abstract][Full Text] [Related]
39. The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.
Andreasson A; Kiss NB; Caramuta S; Sulaiman L; Svahn F; Bäckdahl M; Höög A; Juhlin CC; Larsson C
Epigenetics; 2013 Dec; 8(12):1347-54. PubMed ID: 24149047
[TBL] [Abstract][Full Text] [Related]
40. Array-comparative genomic hybridization in sporadic benign pheochromocytomas.
van Nederveen FH; Korpershoek E; deLeeuw RJ; Verhofstad AA; Lenders JW; Dinjens WN; Lam WL; de Krijger RR
Endocr Relat Cancer; 2009 Jun; 16(2):505-13. PubMed ID: 19153209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
